Research and Development

Our research group is working on over 50 projects, not only involving hyaluronic acid, through the constant dialogue between different functions: discovery, formulation development, pre-clinical and clinical research, pharmacovigilance, regulatory affairs and marketing.

 

We have implemented numerous pre-clinical and clinical studies in collaboration with prestigious international centres for research.

 

We have a large portfolio of patents worldwide – about 1,400 – of which more than 1.200 related to hyaluronic acid with different molecular weights, industrial processes, pharmaceutical formulations, compositions and applications.

Fidia has filed patents initially in Italy and subsequently worldwide, so as to give products, processes and therapeutic uses an international coverage. Over time, we have continued to file patents not only to give new products or new therapeutic applications coverage, but also to ensure intellectual property of the processes of production and purification of HA from various sources, according to the interests of the company.